Neurocognitive Health and Dementia Prevention
Clinical research activity includes older adults at elevated dementia risk who remain free of overt cognitive impairment, with a focus on preserving cognitive function and slowing decline. The work centres on multimodal prevention strategies in people enriched for APOE ε4 risk.
- cognitive decline
- dementia prevention
- multimodal lifestyle intervention
- metabolic support
Interest in this area reflects a therapeutic emphasis on maintaining brain health in ageing populations with identifiable risk factors for neurodegenerative disease.
HIV and Viral Remission Maintenance
Research activity in HIV focuses on sustaining virological control after interruption of standard treatment, with attention to immune-based approaches that support longer periods of remission. The sponsor’s portfolio includes studies of broadly neutralising antibody strategies aimed at controlling viral rebound.
- HIV remission
- broadly neutralising antibodies
- viral suppression
- antiretroviral-free control
This area highlights a therapeutic interest in advanced immunotherapy for chronic viral disease.
Eosinophilic Granulomatosis with Polyangiitis
Clinical studies also address eosinophilic granulomatosis with polyangiitis (EGPA), a complex vasculitic and eosinophilic inflammatory disorder. The research examines treatment options intended to maintain remission and improve disease control in adults with this rare immune-mediated condition.
- EGPA
- vasculitis
- eosinophilic inflammation
- remission maintenance
The therapeutic focus lies in targeted management of severe inflammatory disease with potential relevance to specialised respiratory and immunology care.
Immune and Inflammatory Therapeutics
Across its funded trials, the sponsor shows a strong interest in immune modulation and interventions that act on inflammatory or antiviral pathways. This includes work spanning chronic infection, systemic inflammation, and conditions where targeted biologic approaches may alter disease course.
- biologic therapy
- immune-mediated disease
- inflammatory pathway targeting
- chronic disease control
The portfolio reflects engagement with therapies relevant to specialist medicine, including neurology, infectious disease, and rheumatology.
